SMC approves Xermelo for carcinoid syndrome diarrhoea
13 June 2018 | By European Pharmaceutical Review
Scotland is the first country in the UK to enable patients, battling this serious and debilitating condition, access to a new treatment option...
List view / Grid view
Formulation
Better outcomes for patients using single-pill combination for hypertension
12 June 2018 | By European Pharmaceutical Review
Findings may represent simple and potentially low-cost intervention...
Weekly injections shows HIV-1 viral suppression
11 June 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Results from a pivotal trial of a new HIV therapy, show that PRO 140 is an effective, long-acting therapeutic for previously treated HIV-1 infected patients...
OPTEL to showcase an entirely serialised line for the first time in Europe at Achema 2018
8 June 2018 | By Optel Group
OPTEL GROUP, a leading global provider of traceability systems for diverse industries, namely for pharmaceuticals, medical devices, healthcare, food and natural resources, announced today that it will be exhibiting an entirely serialised line at this year’s edition of Achema, from 11 - 15 June 2018, in Frankfurt, Germany, at Stand F31…
Metformin found to be safe for most diabetics with kidney disease
6 June 2018 | By European Pharmaceutical Review
Acidosis related to use of metformin seen only in those with severely decreased kidney function...
Talazoparib shows promise for early-stage BRCA+ breast cancer patients
5 June 2018 | By Dr Zara Kassam (European Pharmaceutical Review), zae
Once-daily oral pill could replace preoperative chemotherapy in patient population if validated in larger trials...
NanoFlares help to detect serious scarring of wounds
5 June 2018 | By European Pharmaceutical Review
Scientists have developed a new way of seeing when heavy wound scars are forming and providing doctors with the chance to intervene...
DNA-based vaccine treatment for colorectal cancer to undergo first human study
24 May 2018 | By European Pharmaceutical Review
Researchers hope immunotherapy will prevent against overactive immune response...
Eczema drug effective against severe asthma
23 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies...
Bioengineered gel aids brain tissue regrowth after stroke
23 May 2018 | By European Pharmaceutical Review
Replacement neurons, blood vessels fill in stroke cavity; gel provides scaffolding...
A single-injection vaccine for the polio virus
22 May 2018 | By European Pharmaceutical Review
Nanoparticles could offer a new way to help eradicate the disease worldwide...
FDA approves first epoetin alfa biosimilar for the treatment of anaemia
17 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
The FDA has approved Retacrit as a biosimilar to Epogen/Procrit for the treatment of anaemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection...
New molecule to improve pharmaceuticals draws inspiration from nature’s toolbox
16 May 2018 | By European Pharmaceutical Review
New catalyst is specifically tuned to integrate fluorine atoms into a new organic product...
FDA expands approval of Gilenya to treat multiple sclerosis in paediatric patients
16 May 2018 | By European Pharmaceutical Review
The FDA has approved Gilenya to treat relapsing multiple sclerosis in children and adolescents age 10 years and older...
FDA approves Briviact for partial-onset seizures in paediatric epilepsy
15 May 2018 | By European Pharmaceutical Review
The approval provides paediatric epilepsy patients a treatment option which can be initiated at a therapeutic dose from day one...
Follow: